Biognosys and the Michael J. Fox Foundation are partnering to develop biomarkers for parkinson's disease. The partnership involves a project focused on biomarkers, though details of the project's specifics are unclear. A new light scattering detector may be related to the project, as it has been mentioned in the context of characterizing large molecules.